N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)isobutyramide

ID: ALA1632048

PubChem CID: 729610

Max Phase: Preclinical

Molecular Formula: C13H16N2OS

Molecular Weight: 248.35

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)C(=O)Nc1sc2c(c1C#N)CCCC2

Standard InChI:  InChI=1S/C13H16N2OS/c1-8(2)12(16)15-13-10(7-14)9-5-3-4-6-11(9)17-13/h8H,3-6H2,1-2H3,(H,15,16)

Standard InChI Key:  WEQBJUFKTHOGLQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
   23.3225    1.2584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3225    0.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0347    0.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0347    1.6751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7467    1.2584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7466    0.4369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5280    0.1830    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   26.0109    0.8477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5280    1.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8360    0.8476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7830    2.2969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2485    0.1331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0736    0.1331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8360   -0.5814    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4861   -0.5814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4861    0.8476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0382    3.0792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  5  4  1  0
  8 10  1  0
  5  6  2  0
  9 11  1  0
 10 12  1  0
  1  2  1  0
 12 13  1  0
  1  4  1  0
 12 14  2  0
  2  3  1  0
 13 15  1  0
  3  6  1  0
 13 16  1  0
  6  7  1  0
 11 17  3  0
M  END

Associated Targets(Human)

NCI-H727 (447 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-6 (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

fbpC Fibonectin-binding protein C (60 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium smegmatis (8003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vipr1 Vasoactive intestinal polypeptide receptor 1 (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 248.35Molecular Weight (Monoisotopic): 248.0983AlogP: 3.09#Rotatable Bonds: 2
Polar Surface Area: 52.89Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.46CX Basic pKa: CX LogP: 3.84CX LogD: 3.84
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.87Np Likeness Score: -2.36

References

1. Scheich C, Puetter V, Schade M..  (2010)  Novel small molecule inhibitors of MDR Mycobacterium tuberculosis by NMR fragment screening of antigen 85C.,  53  (23): [PMID:21073150] [10.1021/jm100993z]
2. Harikrishnan LS, Srivastava N, Kayser LE, Nirschl DS, Kumaragurubaran K, Roy A, Gupta A, Karmakar S, Karatt T, Mathur A, Burford NT, Chen J, Kong Y, Cvijic M, Cooper CB, Poss MA, Trainor GL, Wong TW..  (2012)  Identification and optimization of small molecule antagonists of vasoactive intestinal peptide receptor-1 (VIPR1).,  22  (6): [PMID:22365758] [10.1016/j.bmcl.2012.01.082]

Source